New hope for lung cancer patients when first treatment fails

NCT ID NCT07279935

Summary

This study tests whether adding chemotherapy to the drug osimertinib helps control lung cancer that has spread to other parts of the body after initial treatment. The trial will enroll about 100 patients in China whose lung cancer returned despite previous surgery and medication. Researchers will measure how long the cancer stays under control and how patients respond to this combination treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Research Site

    Beijing, 100021, China

  • Research Site

    Beijing, 100044, China

  • Research Site

    Beijing, 100142, China

  • Research Site

    Chengdu, 610041, China

  • Research Site

    Chongqing, 400016, China

  • Research Site

    Fuzhou, 350001, China

  • Research Site

    Fuzhou, 350005, China

  • Research Site

    Guangzhou, 510080, China

  • Research Site

    Guangzhou, 510100, China

  • Research Site

    Guangzhou, 510289, China

  • Research Site

    Hangzhou, 310020, China

  • Research Site

    Hefei, 230022, China

  • Research Site

    Hefei, 230031, China

  • Research Site

    Jinan, 250014, China

  • Research Site

    Kunming, 650118, China

  • Research Site

    Nanchang, 330006, China

  • Research Site

    Nanjing, 2100008, China

  • Research Site

    Nanjing, 210009, China

  • Research Site

    Ningbo, 315010, China

  • Research Site

    Shandong, China

  • Research Site

    Shanghai, 200030, China

  • Research Site

    Shanghai, 200433, China

  • Research Site

    Shenyang, 110004, China

  • Research Site

    Shenyang, 110042, China

  • Research Site

    Tianjin, 300060, China

  • Research Site

    Wuhan, 430022, China

  • Research Site

    Wuhan, 430030, China

  • Research Site

    Xi'an, 710004, China

  • Research Site

    Xi'an, 710061, China

  • Research Site

    Zhengzhou, 450008, China

Conditions

Explore the condition pages connected to this study.